First-in-human phase I clinical trial of NY-ESO-1 protein cancer vaccine with a novel adjuvant MIS416, NOD2 and TLR9 stimulant, for patients with NY-ESO-1 expressing solid tumors.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e15176-e15176 ◽  
Author(s):  
Mikiya Ishihara ◽  
Yasutaka Tono ◽  
Yoshihiro Miyahara ◽  
Naozumi Harada ◽  
Shinichi Kageyama ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Cancer Vaccine ◽  
Phase I Clinical Trial

Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors

2016 ◽  
Vol 166-167 ◽  
pp. 48-58 ◽  
Author(s):  
Mutsunori Murahashi ◽  
Yasuki Hijikata ◽  
Kazunari Yamada ◽  
Yoshihiro Tanaka ◽  
Junji Kishimoto ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Cancer Vaccine ◽  
Phase I Clinical Trial ◽  
Advanced Solid Tumors

scholarly journals First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors

2020 ◽  
Vol 69 (4) ◽  
pp. 663-675 ◽  
Author(s):  
Mikiya Ishihara ◽  
Yasutaka Tono ◽  
Yoshihiro Miyahara ◽  
Daisuke Muraoka ◽  
Naozumi Harada ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Cancer Vaccine ◽  
Phase I Clinical Trial

scholarly journals A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy

2012 ◽  
Vol 70 (6) ◽  
pp. 843-853 ◽  
Author(s):  
Michael J. Pishvaian ◽  
Rebecca Slack ◽  
Eunice Y. Koh ◽  
Jan H. Beumer ◽  
Marion L. Hartley ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Standard Therapy ◽  
Phase I Clinical Trial

A phase I clinical trial of QBI-139, a human ribonuclease variant, in solid tumors.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. TPS146-TPS146 ◽  
Author(s):  
L. E. Strong ◽  
J. A. Kink ◽  
B. Mei ◽  
M. N. Shahan ◽  
R. T. Raines
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Clinical Trial

Phase I clinical trial of temozolomide and methoxyamine (TRC-102) in patients with advanced solid tumors.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 2558-2558 ◽  
Author(s):  
Jennifer Rachel Eads ◽  
Smitha S. Krishnamurthi ◽  
Joel N. Saltzman ◽  
Neal J. Meropol ◽  
Joseph A. Bokar ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Clinical Trial ◽  
Advanced Solid Tumors

Regorafenib and nivolumab combination therapy for advanced and metastatic solid tumors: Phase I clinical trial (EPOC1603).

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. TPS3124-TPS3124
Author(s):  
Shota Fukuoka ◽  
Hiroki Hara ◽  
Satoshi Shimizu ◽  
Hideaki Takahashi ◽  
Masafumi Ikeda ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Combination Therapy ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Clinical Trial

scholarly journals A phase I clinical trial of an adenovirus-mediated endostatin gene (E10A) in patients with solid tumors

2007 ◽  
Vol 6 (5) ◽  
pp. 648-653 ◽  
Author(s):  
Xubin Lin ◽  
Huiqiang Huang ◽  
Su Li ◽  
Hongli Li ◽  
Yuhong Li ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Clinical Trial
Sign in / Sign up

Export Citation Format

Share Document